Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

9.16USD
21 Sep 2018
Change (% chg)

$0.43 (+4.93%)
Prev Close
$8.73
Open
$8.73
Day's High
$9.21
Day's Low
$8.55
Volume
229,367
Avg. Vol
75,379
52-wk High
$12.00
52-wk Low
$3.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 1.16 1.50 0.00 0.00
Quarter Ending Dec-18 5 0.98 1.50 0.00 0.00
Year Ending Dec-18 5 5.43 6.90 3.89 1.95
Year Ending Dec-19 6 2.03 6.40 0.00 6.01
Earnings (per share)
Quarter Ending Sep-18 5 -0.45 -0.35 -0.53 -0.54
Quarter Ending Dec-18 5 -0.41 -0.22 -0.53 -0.55
Year Ending Dec-18 5 -1.80 -1.49 -2.01 -2.18
Year Ending Dec-19 5 -2.29 -1.48 -3.76 -2.52
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta -- 0.61 0.87
Price to Sales (TTM) 30.50 110.30 6.46
Price to Book (MRQ) 2.73 12.48 3.90
Price to Tangible Book (MRQ) 2.75 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 60.78 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago 36.52 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago 2.74 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago 0.04 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 12.78 5.49 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.24
Total Debt to Equity (MRQ) 0.00 18.62 14.06
Interest Coverage (TTM) -- -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -486.49 -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -490.71 -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -480.92 -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -480.92 -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 154,209 5,335,375 714,979,821
Net Income/Employee (TTM) -741,628 -5,831,664 82,568,832
Receivable Turnover (TTM) 2.41 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.09 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -43.43 0.80 9.75
Return on Assets - 5 Yr. Avg. -- 2.53 10.91
Return on Investment (TTM) -46.81 1.50 12.72
Return on Investment - 5 Yr. Avg. -- 2.04 14.03
Return on Equity (TTM) -46.88 0.19 14.85
Return on Equity - 5 Yr. Avg. -- -2.23 15.38
  1 Year 3 Year 5 Year
Sales % 12.47 -- --
EPS (TTM) % 18.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.52%
# of Holders: 99
Total Shares Held: 17,558,240
3 Mo. Net Change: 6,243,436
# New Positions: 50
# Closed Positions: 6
# Increased Positions: 80
# Reduced Positions: 12
# Net Buyers: 68
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.